The Alliance

Spotlight Series

The Alliance Spotlight Series is a recurring one-page publication for front-line healthcare professionals, offering quick-takes on critical topics affecting the field of organ donation and transplantation. We encourage you to download these issues and share them with your front-line colleagues and partners.

Spotlight Series Past Issues

Exclusive Access

Take advantage of our 2021 professional partnership levels of support to receive exclusive early access to The Alliance Insight Series publications.

You’ll still have access to all our materials when they go online one month after publication.

*Bronze Circle is a one-time introductory level for first-time Professional Partner organizations. While this opportunity carries limited benefits, it is intended to provide introductory access to The Alliance’s diverse programs and learning solutions. Current Professional Partners are exempt from this option.
Volume VIII ,
Issue 4
DCDD AdobeStock 388849220 Scaled
The creation of new perfusion machines, the use of which have been well established in kidneys, significantly increasing kidney usage for transplantation, were now emerging for the lungs, heart and most recently the liver.

Introduction to NRP and Perfusion in DCD: What Do These Concepts Mean?

In December 2019, Duke University performed the US’ first heart transplant from a donation after circulatory determination of death (DCD) case. Prior to this announcement, the preferred donor for hearts was a donor after neurologic determination of death (DND). There were concerns about the risk of warm ischemic damage to the cardiac tissue throughout the dying process and death and up to the time of heart recovery; and there was no way for physicians to assess the heart function prior to utilizing it for transplantation.

The creation of new perfusion machines, the use of which have been well established in kidneys, significantly increasing kidney usage for transplantation, were now emerging for the lungs, heart and most recently the liver. In other countries, these perfusion machines had already been utilized with promising results. The US’ approval of the use of these perfusion machines were the key to opening the door to pursuing DCD heart recovery.

Today, there are several perfusion options and more in development.  The first heart perfusion machine, Organ Care System (OCS) Heart is “a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state”, according to Transmedics. By placing the DCD heart onto the OCS (ex situ, i.e. outside of the human body) the heart can be successfully resuscitated, preserved, assessed and possibly reconditioned prior to transplantation (Qin et al, 2022).

Normothermic Regional Perfusion (NRP)

Another approach to facilitate improved organ function post cessation of circulation in a DCD case, is the use of Normothermic Regional Perfusion. Some have described the use of NRP as an innovation facilitating the stewardship of the gift of the donor.

Normothermic regional perfusion (NRP) is an in situ perfusion of a portion of the donor’s body with the help of extracorporeal organ support (ECOS).

In live patient care (non-donation situations), ECOS artificially supports lung and or heart function by using a machine that oxygenates a patient’s blood outside of the body and returns it to the patient through the use of a pump. Utilizing this machine allows the heart and lungs to rest and therefore can promote healing of organs (UCSF Fresno). ECOS is regularly utilized in cardiothoracic care of critical patients. (In live patient care, it may be called extracorporeal life support ‘ECLS’.)

The use of ECOS in DCD allows for circulation to be re-established after cardiac cessation has occurred and a certain “hands-off” period (typically 5 mins) was observed prior the first incision being made. The re-established circulation will be limited to a specific area of the body, either isolated to the abdominal area (A-NRP) or both in the abdominal and thoracic area (TA-NRP). Hence the term “regional perfusion”, indicating the perfusion is facilitated with the help of the ECOS in a specific region of the body, excluding the brain or brain stem. NRP

To keep the perfusion ‘regional’, after the sternotomy and a pericardiotomy has been performed, the arch vessels (including the cerebral arteries) are clamped and vented to prevent brain perfusion, and the aorta and right atrium are cannulated to allow for initiation of the circulatory support. (For a more detailed description read Shah’s article 2022.)

The recipients and donor families are respectively informed of the use of the new technique and details of the procedure are shared if they wish for more specific information.

Early results of this new technique are mirroring the findings of other countries, such as Australia, UK, France, Italy, and Spain, who have a few more years of experience in performing this procedure. The hearts are being transplanted with positive results, adding a significant amount of hearts being available for those who are in desperate need of transplant. An additional early positive finding, such as described by Sellers et al. (2022), is the improved liver function of the donated liver following the use of NRP, which may also increase the number of livers available for transplant.

Ultimately, the use of NRP and perfusion devices can facilitate better outcomes and improvement in the stewardship of the gift that the donor and their family have made.

Helpful Resources

References:

Questions & Comments

Please send all questions and/or feedback to [email protected].

A special thanks to Dr. Marty Sellers and Margaret Strang for reviewing the content of this issue.

Worth Sharing
Volume VIII, Issue 4

A Special Thanks to This Series’ Contributors

Hedi Aguiar
Speaker
Hedi Aguiar
RN, MSN
Program Consultant
Organ Donation and Transplantation Alliance
Deanna Fenton
About the Editor |
Deanna Fenton

Deanna is a knowledgeable and versatile professional with diverse experiences in healthcare, client relations, marketing, project management and demonstrated skills in leadership and advocacy. Prior to joining The Alliance, she worked in Hospital Development at her local OPO in the state of New Jersey where she served as the clinical liaison to a number of Level 1 Trauma & Neuroscience centers as well as community hospitals. Her personal connection as a donor family and friend fuels her passion to support her colleagues across the donation-transplantation continuum through the development of valuable educational resources that ultimately boost performance and improve outcome measures. Deanna holds a Bachelor of Arts in Psychology and a minor degree in Public Health from Montclair State University. In her spare time, Deanna enjoys visiting vineyards, spending time with her family, and traveling in hopes of visiting all seven wonders of the world.

Advancing All.

The Alliance is not a membership organization and therefore relies on annual voluntary financial support from OPOs and transplant programs who find value in our programs and initiatives.

We invite you to join us as a 2021 professional partner